Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
Thursday, November 5, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

CCTA matches IVUS for PCI guidance: Imaging expert Carlos Collet breaks down the data

In terms of the study's primary endpoint, using CCTA to guide procedures was noninferior to IVUS. CCTA was also linked to certain advantages over IVUS, including improved cath lab efficiency. 

READ MORE >
Carlos Collet, MD, PhD, Director, Cardiovascular Imaging, Physiology, and Translational Therapeutics, Cardiovascular Research Foundation (CRF), explains the P4 trial, which found CCTA-guided PCI is more efficient than IVUS-guided PCI.
Share on Twitter Share on Facebook Share on Linkedin

CCTA matches IVUS for PCI guidance: Imaging expert Carlos Collet breaks down the data

Share on Twitter Share on Facebook Share on Linkedin
Carlos Collet, MD, PhD, Director, Cardiovascular Imaging, Physiology, and Translational Therapeutics, Cardiovascular Research Foundation (CRF), explains the P4 trial, which found CCTA-guided PCI is more efficient than IVUS-guided PCI.
In terms of the study's primary endpoint, using CCTA to guide procedures was noninferior to IVUS. CCTA was also linked to certain advantages over IVUS, including improved cath lab efficiency. 
READ MORE >

Both FDA-approved renal denervation systems linked to positive real-world outcomes

The real-world benefits of renal denervation were a hot topic at TCT 2026 in San Diego.

READ MORE >
Paradise Ultrasound image courtesy of Recor Medical. New data on the RDN systems from Recor Medical and Medtronic confirmed that this relatively new technology brings long-term relief to patients with uncontrolled hypertension.
Share on Twitter Share on Facebook Share on Linkedin

Both FDA-approved renal denervation systems linked to positive real-world outcomes

Share on Twitter Share on Facebook Share on Linkedin
Paradise Ultrasound image courtesy of Recor Medical. New data on the RDN systems from Recor Medical and Medtronic confirmed that this relatively new technology brings long-term relief to patients with uncontrolled hypertension.
The real-world benefits of renal denervation were a hot topic at TCT 2026 in San Diego.
READ MORE >

New stroke prevention device for TAVR falls short, raising questions about the value of embolic protection

A new-look cerebral embolic protection device for TAVR is safe to use and consistently captures debris. According to late-breaking data presented at TCT 2026, however, the device failed to demonstrate any tangible clinical benefits.

READ MORE >
ProtEmbo Cerebral Protection System
Share on Twitter Share on Facebook Share on Linkedin

New stroke prevention device for TAVR falls short, raising questions about the value of embolic protection

Share on Twitter Share on Facebook Share on Linkedin
ProtEmbo Cerebral Protection System
A new-look cerebral embolic protection device for TAVR is safe to use and consistently captures debris. According to late-breaking data presented at TCT 2026, however, the device failed to demonstrate any tangible clinical benefits.
READ MORE >

Featured Articles

Combination blood pressure drug recalled after failed quality test

Two lots of a generic blood pressure medication were recalled because the drugs may be ineffective. The FDA ruled this as a Class II recall. 

READ MORE >
Based on this evidence, its is recommended using monotherapy with ticagrelor or prasugrel after one to three months of DAPT after PCI for acute coronary syndrome (ACS), but not using monotherapy of aspirin or clopidogrel unless the patient has a high bleeding risk.
Share on Twitter Share on Facebook Share on Linkedin

Combination blood pressure drug recalled after failed quality test

Share on Twitter Share on Facebook Share on Linkedin
Based on this evidence, its is recommended using monotherapy with ticagrelor or prasugrel after one to three months of DAPT after PCI for acute coronary syndrome (ACS), but not using monotherapy of aspirin or clopidogrel unless the patient has a high bleeding risk.
Two lots of a generic blood pressure medication were recalled because the drugs may be ineffective. The FDA ruled this as a Class II recall. 
READ MORE >

Energy drinks and stimulant supplements linked to several serious heart risks

Researchers reviewed an FDA safety database, finding that these products were commonly involved in reports related to cardiac arrest, heart attacks, ventricular arrhythmias, heart palpitations, chest pain and fainting.

READ MORE >
energy drink
Share on Twitter Share on Facebook Share on Linkedin

Energy drinks and stimulant supplements linked to several serious heart risks

Share on Twitter Share on Facebook Share on Linkedin
energy drink
Researchers reviewed an FDA safety database, finding that these products were commonly involved in reports related to cardiac arrest, heart attacks, ventricular arrhythmias, heart palpitations, chest pain and fainting.
READ MORE >

GLP-1 drugs outperform metformin in patients with prediabetes

Metformin is typically the therapy of choice for patients with prediabetes, but GLP-1 drugs appear to offer several benefits.

READ MORE >
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

GLP-1 drugs outperform metformin in patients with prediabetes

Share on Twitter Share on Facebook Share on Linkedin
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
Metformin is typically the therapy of choice for patients with prediabetes, but GLP-1 drugs appear to offer several benefits.
READ MORE >

Cannabis use may increase risk of CVD, stroke—even for those who only occasionally partake

“We expected that the chances of heart disease would gradually rise as people used cannabis more often, but that wasn’t the case," one researcher said. "Both low-use and heavy-use groups had higher odds of developing heart disease."

READ MORE >
cannabis use disorder marijuana joint weed smoking
Share on Twitter Share on Facebook Share on Linkedin

Cannabis use may increase risk of CVD, stroke—even for those who only occasionally partake

Share on Twitter Share on Facebook Share on Linkedin
cannabis use disorder marijuana joint weed smoking
“We expected that the chances of heart disease would gradually rise as people used cannabis more often, but that wasn’t the case," one researcher said. "Both low-use and heavy-use groups had higher odds of developing heart disease."
READ MORE >

In Case You Missed It

PCI before TAVR may still be safest strategy for some heart patients

The recent PRO-TAVI trial showed that care teams can safely perform PCI at a later date when patients undergoing TAVR present with concomitant coronary artery disease. According to this latest analysis, however, there may still be certain patients who benefit from undergoing PCI prior to TAVR.

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

PCI before TAVR may still be safest strategy for some heart patients

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
The recent PRO-TAVI trial showed that care teams can safely perform PCI at a later date when patients undergoing TAVR present with concomitant coronary artery disease. According to this latest analysis, however, there may still be certain patients who benefit from undergoing PCI prior to TAVR.
READ MORE >

Exploring major trends in cardiac MRI

Cardiac MRI scans are delivering more and more value as time goes on, in part thanks to the continued rise of AI. 

READ MORE >
Amit Patel, MD, FSCCT, secretary of the Society for Cardiovascular Magnetic Resonance (SCMR), director of cardiac imaging and professor of medicine at the University of Virginia Health System in Charlottesville, outlined four key areas where cardiac MRI is expanding its clinical value, along with the growing role of artificial intelligence (AI) in making advanced imaging techniques more practical for routine clinical use. #CMR #SCMR #CardiacMR
Share on Twitter Share on Facebook Share on Linkedin

Exploring major trends in cardiac MRI

Share on Twitter Share on Facebook Share on Linkedin
Amit Patel, MD, FSCCT, secretary of the Society for Cardiovascular Magnetic Resonance (SCMR), director of cardiac imaging and professor of medicine at the University of Virginia Health System in Charlottesville, outlined four key areas where cardiac MRI is expanding its clinical value, along with the growing role of artificial intelligence (AI) in making advanced imaging techniques more practical for routine clinical use. #CMR #SCMR #CardiacMR
Cardiac MRI scans are delivering more and more value as time goes on, in part thanks to the continued rise of AI. 
READ MORE >

Weightlifters do significant heart damage when taking anabolic steroids—but there is hope

Steroid users can undo at least some of the damage if they simply stop taking them. 

READ MORE >
gym
Share on Twitter Share on Facebook Share on Linkedin

Weightlifters do significant heart damage when taking anabolic steroids—but there is hope

Share on Twitter Share on Facebook Share on Linkedin
gym
Steroid users can undo at least some of the damage if they simply stop taking them. 
READ MORE >

In Other News

FTC warns 25 insurance brokers not to engage in deceptive marketing for ACA plans

The agency did not name the companies or accuse them of wrongdoing. Instead, it told the companies they are ‘on notice’ and reminded them about federal laws, including the limited use of telemarketing.

READ MORE >
smartphone.jpg
Share on Twitter Share on Facebook Share on Linkedin

FTC warns 25 insurance brokers not to engage in deceptive marketing for ACA plans

Share on Twitter Share on Facebook Share on Linkedin
smartphone.jpg
The agency did not name the companies or accuse them of wrongdoing. Instead, it told the companies they are ‘on notice’ and reminded them about federal laws, including the limited use of telemarketing.
READ MORE >

CVS Health to spin off its retail pharmacies into new company after regulatory pressure

The big announcement was made on Wednesday, and many of the details are still being worked out ahead of the planned 2028 split of the company. For now, the plan is for CVS Health to retain its core Caremark and Aetna businesses, with the pharmacy company to take over prescription drug sales and urgent care services.

READ MORE >
cvs-health-healthhub-location-at-cvs-pharmacy-store-image.jpg
Share on Twitter Share on Facebook Share on Linkedin

CVS Health to spin off its retail pharmacies into new company after regulatory pressure

Share on Twitter Share on Facebook Share on Linkedin
cvs-health-healthhub-location-at-cvs-pharmacy-store-image.jpg
The big announcement was made on Wednesday, and many of the details are still being worked out ahead of the planned 2028 split of the company. For now, the plan is for CVS Health to retain its core Caremark and Aetna businesses, with the pharmacy company to take over prescription drug sales and urgent care services.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup